EUVIMEDEUVIMED entdecken
Übersichtsarbeit

mTOR inhibitors in targeting autophagy and autophagy-associated signaling for cancer cell death and therapy

Prakash Kumar Senapati, Kewal Kumar Mahapatra, Amruta Singh, Sujit Kumar Bhutia

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2025-07 · 1880 (3) · 189342

DOI: 10.1016/j.bbcan.2025.189342 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2025-07. Verfasst von Prakash Kumar Senapati und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cancer and Cell Death Laboratory, Department of Life Science, National Institute of Technology, Rourkela, Odisha 769008, India. Hauptthemen laut MEDLINE: Neoplasms, Autophagy, TOR Serine-Threonine Kinases, MTOR Inhibitors. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 188 Literaturangaben. Gefördert von: Department of Biotechnology, Department of Science and Technology, Ministry of Science and Technology, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The mechanistic target of rapamycin (mTOR) is a protein kinase that plays a central regulatory switch to control multifaceted cellular processes, including autophagy. As a nutrient sensor, mTOR inhibits autophagy by phosphorylating and inactivating key regulators, including ULK1, Beclin-1, UVRAG, and TFEB, preventing autophagy initiation and lysosomal biogenesis. It also suppresses autophagy-related protein expression, prioritizing growth over cellular recycling. Under nutrient deprivation, mTORC1 activity decreases, allowing autophagy to restore cellular homeostasis. Hyperautophagic activities lead to autophagic cell death; sometime after the point of no return, the cell goes for non-apoptotic, non-necrotic cell death i.e., Autosis. In cancer, the crosstalk between autophagy and mTOR is context-dependent, driving either cell survival or autophagy-dependent cell death. Using mTOR inhibitors, autophagic cell death can be induced to regulate cell growth, and proliferation is a potential therapeutic option for cancer treatment. mTOR inhibitors are broadly categorized into two types, i.e., natural and synthetic mTOR inhibitors. Although several studies in preclinical and clinical trials of various synthetic mTOR inhibitors are now in focus for cancer therapies, limited work has been done to explore autophagic cell death-inducing mTOR inhibitors. In addition, many natural mTOR inhibitors display better efficacy over synthetic mTOR inhibitors due to their lower toxicity, biocompatibility, and potential to overcome drug resistance in inducing autophagic cell death for cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsAutophagyTOR Serine-Threonine KinasesMTOR InhibitorsAntineoplastic AgentsHumansSignal TransductionAnimals

Stichwörter der Autor:innen

Autophagic cell deathAutophagyCancer therapymTOR inhibitorsmTOR signaling

Substanzen

TOR Serine-Threonine KinasesMTOR InhibitorsMTOR protein, humanAntineoplastic Agents

Autor:innen und Institutionen

  • Cancer and Cell Death Laboratory, Department of Life Science, National Institute of Technology, Rourkela, Odisha 769008, India.
  • Department of Agriculture and Allied Sciences (Zoology), C. V. Raman Global University Bhubaneswar, Odisha-752054, India.
  • Cancer and Cell Death Laboratory, Department of Life Science, National Institute of Technology, Rourkela, Odisha 769008, India. Electronic address: sujitb@nitrkl.ac.in.

Förderung

  • Department of Biotechnology
  • Department of Science and Technology, Ministry of Science and Technology, India

Zitieren

APA

Senapati, P. K., Mahapatra, K. K., Singh, A., & Bhutia, S. K. (2025). mTOR inhibitors in targeting autophagy and autophagy-associated signaling for cancer cell death and therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1880(3), 189342. https://doi.org/10.1016/j.bbcan.2025.189342

Vancouver

Senapati PK, Mahapatra KK, Singh A, Bhutia SK. mTOR inhibitors in targeting autophagy and autophagy-associated signaling for cancer cell death and therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2025;1880(3):189342. doi:10.1016/j.bbcan.2025.189342

BibTeX
@article{Senapati2025,
  author = {Senapati, Prakash Kumar and Mahapatra, Kewal Kumar and Singh, Amruta and Bhutia, Sujit Kumar},
  title = {mTOR inhibitors in targeting autophagy and autophagy-associated signaling for cancer cell death and therapy},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2025},
  volume = {1880},
  number = {3},
  pages = {189342},
  doi = {10.1016/j.bbcan.2025.189342}
}
Kostenlos starten →